Genmab — April 2019
-
Har lige skrevet en større analyse om tålmodig investering ind i de lange megatrends. Her har jeg Genmab med: "Med lægemidlet Darzalex mod knoglemarvskræft rammer Genmab-casen ind i en global sundhedstendens, hvor mennesker lever længere. Knoglemarvskræft opstår hyppigere med alderen og der forventes en stor stigning i antallet mennesker med den alvorlige sygdom i de næste mange år".
-
Og ja Vitus...Jeg er meget tålmodig som altid.
-
God morgen.
-
God morgen. :-). Teprutumumab. Måske den har været vist. ?? https://www.fiercebiotech.com/biotech/new-phase-3-data-paints-fuller-picture-for-horizon-s-teprotumumab-aace?mkt_tok=eyJpIjoiWlRoaFlUY3lOemhpTXpkaSIsInQiOiJTaG1IcXNUYTg1M0RjK05FRlU1N2FvZUkzblJIZGl3MTlHbUpIUDlVQ0JJUmpYdktzeHU2bGFIZ2cwTnoxVGZpRDdlXC9TS2puT1NyeVwva0NBQjJBViszVUJXODV3eXZrNmNEVkRvUkNYb2RqRGlBak5aS3BCb2VROHROSnRkTlVtIn0%3D&mrkid=41140432
-
it will surprise me if they can not now take out 1100 to hit some stops. and then we'll see if we can bounce again or not... Typical; holiday week, month end and tomorrow most markets closed; easy to push price wherever you want with only little capital...
-
Fy for den idag.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind